Clinical Trials, Criminal Acts
- pressgiismun2025
- Jul 26
- 2 min read

FUSS is currently engulfed in turmoil. What began as a public health emergency has spiraled into a scandal characterized by medical negligence, corruption, and egregious human rights violations. At the heart of this crisis is Virexia-69, a rapidly spreading and highly infectious virus that has gripped several member states. In a desperate attempt to combat the outbreak, the Baljit Laboratory hastily developed a vaccine that, rather than offering hope, has unleashed catastrophe.
According to a recently leaked Human Rights report, the Baljit vaccine has proven not only ineffective but also lethally dangerous. Trial subjects began to die in alarming numbers, revealing that the vaccine posed greater risks than the virus it aimed to combat.
The public was further shocked to learn that the vaccine trials were conducted on death row inmates and that the senators from Hawaii, Delaware, Mississippi, and Indiana signed off on the testing of this vaccine. Their justification? The inmates were "already set to die," rendering the testing "not unethical." In a chilling display of priorities, the delegate of Hawaii responded to the report by inquiring about the vaccine's “profit margins,” rather than addressing the profound human costs involved in the trials.
The fallout continued as Barrack Ladin, a delegate intricately linked to the vaccine's development and rollout, was reluctantly pushed to engage in committee debate. Pressured to pose a Point of Information despite the crisis implicating him directly
Critics argue that this incident goes beyond mere medical malpractice; it embodies a horrifying use of execution disguised as scientific progress. The vaccine has morphed into a hidden death sentence, obscuring the boundary between authentic public health initiatives and government-sanctioned punishment. As confidence in the system erodes and tensions rise, FUSS confronts a grim truth: the emphasis on profit is overshadowing the welfare of individuals.
Hana Mukunu,
Xinhua News
%20(3000%20x%201333%20px)_edited.png)



Comments